Jane Pritchett Henderson serves as the Chief Financial Officer at Apogee Therapeutics Inc., a position she has held since the company's inception. With over two decades of experience in financial management within the biotechnology and pharmaceutical industries, Henderson has become a pivotal figure in steering Apogee's financial strategy. Before joining Apogee, she held the role of CFO at several high-profile biotech firms, where she was instrumental in guiding them through successful IPOs and subsequent growth phases. Her expertise in capital markets, strategic financial planning, and corporate development has been crucial in positioning Apogee for sustained growth and innovation. Henderson's career is marked by numerous achievements that highlight her strategic acumen and leadership. She played a key role in securing significant funding rounds for her previous employers, enabling them to advance their research and development pipelines. Her ability to navigate complex financial landscapes and forge strong investor relationships has earned her a reputation as a trusted and visionary leader in the biotech sector. At Apogee, Henderson oversees all aspects of the company's financial operations, including budgeting, forecasting, and financial reporting. Her strategic insights are integral to Apogee's mission to develop transformative therapies for patients with serious diseases. In addition to her professional responsibilities, Henderson is committed to fostering diversity and inclusion within the biotech industry. She actively mentors young professionals and participates in initiatives aimed at increasing representation of underrepresented groups in STEM fields. Her dedication to both her company's success and the broader industry's advancement underscores her role as a dynamic and influential leader at Apogee Therapeutics Inc.